GARDASIL 9 40 ug/.5mL

GARDASIL 9 is a 9-valent HPV vaccine designed to help prevent certain HPV-related conditions. This recombinant vaccine is administered via intramuscular injection and is available in single-dose vials.

GARDASIL 9 is primarily used for the prevention of diseases caused by nine types of human papillomavirus (HPV). These include certain cancers and genital warts. The vaccine is often recommended for individuals to help reduce the risk of HPV-related health issues.

Common effects of GARDASIL 9 may include mild to moderate reactions at the injection site, such as pain, swelling, or redness. Some individuals might also experience temporary symptoms like headache, fatigue, or muscle pain following vaccination.

GARDASIL 9 should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to discuss any medical conditions or allergies with a healthcare provider before receiving the vaccine.

GARDASIL 9 is generally considered safe, but interactions with other medications or vaccines are not well-documented. It is advisable to inform healthcare providers about all current medications and vaccines before receiving GARDASIL 9.